טוען...
Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants
BACKGROUND: The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses. We th...
שמור ב:
| הוצא לאור ב: | BMC Pediatr |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4231464/ https://ncbi.nlm.nih.gov/pubmed/24165292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-176 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|